Preservative Efficacy Testing (PET) Explained

A cosmetic product can look, smell, and feel completely normal while its microbial protection is beginning to fail.

That is what makes preservation different from many other areas of product development.

A broken pump is visible.

A separated emulsion is visible.

Microbial contamination often is not.

Preservative Efficacy Testing, commonly called PET, preservative challenge testing, or simply a challenge test, evaluates whether a finished product can control microorganisms deliberately introduced under standardized laboratory conditions.

It does not merely confirm that a preservative appears on the ingredient list.

It evaluates whether the complete preservation system works inside the actual formula.

That distinction matters because a preservative can perform well in supplier data, be used within its recommended range, and still prove inadequate in a particular product.

The finished formula is the system that must pass.

What Is Preservative Efficacy Testing?

Preservative Efficacy Testing is a controlled microbiological study designed to assess the antimicrobial protection of a finished product.

During the test, defined microorganisms are intentionally introduced into separate product samples. The laboratory then measures how the microbial populations change at specified intervals.

The central question is:

Can this product reduce or control microbial contamination if organisms enter the formula during manufacturing, filling, storage, or consumer use?

ISO 11930 is the principal international reference standard for evaluating the antimicrobial protection of cosmetic products. The standard combines a preservation efficacy test with a broader assessment of the product’s microbiological risk. It does not apply in the same way to products that have been properly determined to present low microbiological risk.

PET is not proof that contamination can never occur.

It is evidence that the product demonstrated an acceptable level of antimicrobial protection against the selected challenge organisms under the conditions of the test.

PET, Challenge Testing, and Antimicrobial Effectiveness Testing

Several related terms are used across cosmetics, personal care, pharmaceutical development, and laboratory testing.

Preservative Efficacy Testing

This is a common cosmetic-industry term describing the evaluation of a product’s antimicrobial preservation.

Challenge Testing

This term describes the basic concept of deliberately challenging a product with microorganisms and measuring its response.

Antimicrobial Effectiveness Testing

This language is frequently used in pharmaceutical and over-the-counter drug contexts. USP <51> is a pharmacopeial antimicrobial effectiveness test used for applicable pharmaceutical products.

The terms are sometimes used conversationally as though they mean exactly the same thing, but the appropriate protocol depends on:

• Product classification

• Intended market

• Intended use

• Formula type

• Regulatory requirements

• Customer population

• Packaging and exposure risk

• Laboratory capabilities

A conventional cosmetic may be evaluated using ISO 11930.

A United States OTC drug product may require a pharmacopeial approach such as USP <51>.

The protocol should be selected before the study begins, not after the results arrive.

What PET Actually Measures

A PET study evaluates the change in viable microorganism levels over time after the finished product has been deliberately inoculated.

The laboratory generally challenges separate samples with organisms representing major microbial groups, such as:

• Gram-negative bacteria

• Gram-positive bacteria

• Yeast

• Mold

European Scientific Committee on Consumer Safety guidance describes challenge testing as artificial contamination of a finished cosmetic followed by evaluation of the decrease in contamination. The guidance identifies organisms including Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, and Aspergillus brasiliensis. The exact panel and acceptance criteria depend on the method being used.

The laboratory measures surviving organisms at defined time points and reports the change in microbial population, commonly expressed as a logarithmic reduction.

A log reduction describes how substantially the viable population declined.

For example:

• A 1-log reduction means a tenfold decline.

• A 2-log reduction means a hundredfold decline.

• A 3-log reduction means a thousandfold decline.

The required reduction is not identical for every organism, product, protocol, or time point.

The laboratory report should identify:

• The method used

• The microorganisms tested

• The starting inoculum

• Sampling intervals

• Organism recovery results

• Log reductions

• Acceptance criteria

• Final interpretation

• Any deviations or limitations

A report that says only “pass” or “fail” without showing the underlying results provides less useful technical information.

PET Is a Standardized Stress Test, Not a Perfect Simulation of Consumer Use

Challenge testing is designed to create a reproducible way to compare antimicrobial performance.

It does not recreate every condition a product may experience in the real world.

Consumers may:

• Use wet fingers

• Leave a product open

• Store it in a warm bathroom

• Touch the dispensing opening

• Share the product

• Add water accidentally

• Refill an unclean package

• Store it beyond the intended use period

A standardized challenge test cannot model every one of those behaviors.

Instead, it provides controlled evidence that the product can respond to a defined microbial challenge.

That evidence should be considered alongside:

• Packaging design

• Intended use

• Manufacturing hygiene

• Raw-material quality

• Water-system controls

• Stability

• Consumer population

• Storage conditions

• Complaint monitoring

PET is important because it reduces uncertainty. It does not eliminate every possible source of microbial risk.

How Is a Preservative Efficacy Test Performed?

The precise process depends on the selected protocol, but most studies follow the same general sequence.

The laboratory receives the finished product

The submitted material should closely represent the commercial formula.

That means the same:

• Ingredient composition

• Preservative system

• pH

• Fragrance

• Color

• Active ingredients

• Manufacturing process

• Raw-material grades

Testing a simplified laboratory base may help during early development, but it does not qualify the finished commercial product.

The method and recovery system are established

Before meaningful organism counts can be obtained, the laboratory must be able to stop or neutralize the product’s antimicrobial activity when a sample is removed for analysis.

This is a critical technical point.

Without effective neutralization, the preservative may continue killing organisms during laboratory recovery. That can make the formula appear more effective than it actually was during the defined exposure period.

SCCS guidance specifically states that antimicrobial activity remaining in the sampled cosmetic must be controlled through dilution, filtration, neutralizers, or another suitable method.

The product is inoculated

Separate samples are deliberately exposed to calibrated microbial populations.

The samples are stored under controlled conditions

The inoculated products are held according to the test method.

Organisms are recovered and counted

At predetermined intervals, the laboratory measures the surviving microbial population.

The results are compared with protocol criteria

The product is evaluated against the acceptance requirements of the selected method.

Many standard cosmetic challenge programs run for approximately 28 days, although the organisms, intervals, calculations, and acceptance criteria vary by protocol.

Why Neutralization and Method Suitability Matter

PET does not begin with inoculation.

It begins with proving that the laboratory can accurately recover microorganisms from the product.

A formula may contain:

• Oils

• Surfactants

• Polymers

• Clays

• Powders

• Pigments

• Alcohol

• High levels of glycols

• Low-solubility ingredients

• Strong antimicrobial components

These can complicate dilution, recovery, plating, filtration, and organism enumeration.

A qualified laboratory should demonstrate that its recovery method works for the product being tested.

This is sometimes overlooked when brands compare PET quotations.

The least expensive laboratory is not necessarily the best value if it applies the same recovery process to every formula without confirming that the method is suitable.

What Does a Passing PET Result Mean?

A passing result means the product met the acceptance criteria of the selected method under the conditions evaluated.

It supports the conclusion that the finished product demonstrated adequate antimicrobial protection against the challenge organisms used in the study.

A passing PET does not mean:

• The product is sterile

• Contamination is impossible

• The manufacturing facility can ignore hygiene

• Every future batch will automatically be protected

• The product has completed stability testing

• The packaging is compatible

• The full shelf life has been established

• All possible microorganisms were tested

• The formula can withstand unlimited consumer misuse

• Significant future changes can be made without reassessment

PET is one component of a broader microbiological quality strategy.

PET Is Not the Same as Microbial Limits Testing

PET and microbial limits testing answer different questions.

Microbial limits testing asks:

What microorganisms are present in this sample now?

It evaluates the microbial quality of the product at the time of testing.

Preservative Efficacy Testing asks:

Can this product control a defined microbial challenge over time?

A product can have an excellent initial microbial count and still fail PET.

That may mean it was manufactured cleanly but lacks enough antimicrobial protection to control contamination introduced later.

The opposite can also occur.

A formula may have a theoretically capable preservation system but still contain unacceptable contamination because of:

• Poor raw-material quality

• Contaminated water

• Inadequate cleaning

• Unsanitary filling

• Excessive manufacturing hold times

• Contaminated packaging

• Post-production handling

A preservation system should not be expected to compensate for poor manufacturing practices.

FDA notes that cosmetics can become harmful when contaminated with pathogenic bacteria or fungi. Its cosmetic GMP guidance also recommends evaluating fresh and retained finished-product samples for adequacy of preservation under reasonably foreseeable storage and consumer-use conditions.

PET Is Not a Shelf-Life Test

PET contributes to the microbial safety assessment, but it does not establish the complete shelf life of a product.

Shelf-life support may also require:

• Physical stability

• Chemical stability

• Packaging compatibility

• Microbial limits testing

• Active-content testing

• Preservative-content monitoring

• Transportation studies

• Light or thermal exposure

• Retained-sample evaluation

• Product-specific analytical testing

A product can pass PET and still:

• Separate

• Change color

• Lose viscosity

• Oxidize

• Develop an unacceptable odor

• React with its package

• Lose active potency

• Become difficult to dispense

PET answers an important question, but it does not answer every question.

Does Every Cosmetic Product Need PET?

No.

A product may be considered microbiologically low risk when its composition and use conditions do not support meaningful microbial growth.

Potential low-risk characteristics may include:

• Very low water activity

• High alcohol content

• Extreme pH

• Anhydrous composition

• Limited consumer exposure

• Packaging that minimizes contamination

• A combination of conditions hostile to microbial survival

ISO 29621 provides guidance for identifying and evaluating microbiologically low-risk cosmetic products. ISO 11930 also recognizes that products determined to be low risk may not require the standard preservation efficacy test.

The important phrase is determined to be low risk.

A product should not be exempted simply because someone assumes:

• It contains no added water

• It includes essential oils

• It has a low pH

• It contains a high percentage of glycols

• It is packaged in a pump

• It is called “self-preserving”

• It does not use a conventional preservative

A documented microbiological risk assessment is more defensible than a marketing assumption.

Anhydrous Does Not Automatically Mean Risk-Free

A genuinely water-free product may present low microbial growth risk, but real-world use still matters.

An anhydrous scrub stored in a shower may repeatedly receive water from wet hands.

A cleansing balm in a wide-mouth jar may be exposed to fingers, bathroom humidity, and droplets.

A powder may clump or support localized growth after moisture enters the package.

A nominally anhydrous formula may also contain raw materials supplied in aqueous carriers.

The microbiological assessment should consider:

• The formula as manufactured

• The package

• The use environment

• Consumer behavior

• Water introduction

• Raw-material bioburden

• Expected period after opening

“Anhydrous” describes formulation composition. It does not automatically describe the complete use risk.

Is PET Legally Required?

The answer depends on the jurisdiction, product, and risk.

United States

FDA does not publish one universal list of tests required for every cosmetic formula. However, the company responsible for marketing a cosmetic is responsible for ensuring that the product is safe under labeled or customary conditions of use.

Under MoCRA, the responsible person must maintain records supporting adequate substantiation of product safety, and FDA states that supporting data should come from scientifically robust methods.

Therefore, it is more accurate to say:

PET is not a universally mandated named test for every United States cosmetic, but appropriate evidence of microbial safety may be essential to a defensible safety-substantiation program.

For a conventional water-containing cosmetic with foreseeable contamination exposure, omitting preservation evaluation would require a strong scientific justification.

European Union

The EU Cosmetic Product Safety Report must address the microbiological quality of the cosmetic and the results of preservation challenge testing when applicable.

European Commission guidance on the Cosmetic Product Safety Report refers to microbiological quality and challenge-test results as part of the information used in the safety assessment. SCCS guidance states that challenge testing is expected for products that may deteriorate or create an infection risk under normal storage and use.

OTC Drug Products

Products regulated as drugs may be subject to different compendial and regulatory expectations.

For example, certain United States sunscreens and acne treatments are OTC drugs. Their antimicrobial effectiveness testing strategy may involve USP <51> or another appropriate pharmaceutical method.

The method should be confirmed with the regulatory advisor, testing laboratory, formulator, and manufacturer before the study is commissioned.

Preservation Is a System, Not a Single Ingredient

Preservative selection is only one part of microbial protection.

The performance of the complete system may be influenced by:

• Preservative chemistry

• Preservative concentration

• Product pH

• Water activity

• Chelation

• Surfactants

• Emulsifiers

• Polymers

• Electrolytes

• Oils

• Fragrance

• Botanical extracts

• Proteins

• Fermentation-derived materials

• Pigments and powders

• Processing temperature

• Addition order

• Mixing

• Packaging

• Manufacturing hygiene

This is why reviewing an ingredient list cannot confirm that a formula is adequately preserved.

Two formulas may contain the same preservative at the same concentration and perform very differently.

Why Preservative Systems Fail PET

A PET failure is not always evidence that the formulator simply used too little preservative.

Several mechanisms can weaken antimicrobial protection.

The pH is outside the preservative’s effective range

Some preservation systems depend strongly on pH.

Organic acids, for example, generally rely on their undissociated form for a meaningful portion of antimicrobial activity. As pH changes, the balance between dissociated and undissociated forms changes.

A preservative may be legally permitted and present at the intended percentage while delivering inadequate activity at the formula’s final pH.

The preservative is not sufficiently available

The preservative must be available where microbial control is needed.

It may:

• Partition into the oil phase

• Associate with surfactant micelles

• Bind to polymers or proteins

• Adsorb onto clays or pigments

• Crystallize

• Become poorly dispersed

• Interact with packaging

• Lose activity through processing

The total amount listed in the formula is not always the same as the amount functionally available for antimicrobial protection.

Raw materials increase the microbial challenge

Some materials may carry higher bioburden or provide nutrients that make preservation more demanding.

Examples can include:

• Botanical extracts

• Clays

• Starches

• Proteins

• Natural gums

• Fermentation-derived materials

• Unrefined raw materials

This does not make them unsuitable.

It means supplier quality, specifications, handling, and preservation strategy require closer attention.

The system does not adequately control both bacteria and fungi

Some antimicrobial ingredients provide stronger bacterial control than fungal control, or the reverse.

A preservation system must be designed around the likely risk spectrum rather than one favored organism group.

The formula interferes with the preservative

Surfactants, emulsifiers, polymers, salts, fragrances, proteins, and active ingredients may change solubility, availability, or antimicrobial performance.

A preservative that works well in a simple lotion may behave differently in:

• A surfactant cleanser

• A high-electrolyte serum

• A clay mask

• A protein-rich conditioner

• A pigmented cosmetic

• A high-active treatment

The preservative was processed incorrectly

Preservation can be compromised by:

• Excessive heat

• Incorrect addition temperature

• Poor dispersion

• Insufficient mixing

• Wrong addition order

• Long manufacturing hold times

• pH drift after manufacture

• Inconsistent batch processing

Packaging creates greater exposure than expected

A wide-mouth jar used with wet fingers presents a different risk profile than an airless dispenser.

A mascara wand repeatedly returns to the package.

A dropper may touch the skin.

A refill system may introduce contamination from an inadequately cleaned primary package.

Packaging cannot rescue an inadequate formula, but it can materially change the contamination pressure the formula encounters.

Water Percentage Is Not the Same as Water Activity

A product’s total water content is not the only factor governing microbial growth.

Water activity describes how much water is available to support microorganisms.

Two products with similar water percentages may have different water activities because dissolved salts, glycols, sugars, polymers, and other materials bind water differently.

Water activity can therefore contribute to a risk assessment, particularly for concentrated, high-solids, or unconventional formulas.

It should not be treated as a universal substitute for PET.

A low water-activity result must be interpreted in the context of:

• Product composition

• Measurement method

• Organism risk

• Packaging

• Consumer use

• Manufacturing conditions

Hurdle Technology in Cosmetic Preservation

Strong preservation systems often use several compatible controls rather than expecting one preservative to carry the entire burden.

Potential hurdles include:

• An approved preservative system

• Controlled pH

• Reduced water activity

• Chelation

• Glycols or multifunctional ingredients

• Alcohol

• Hygienic manufacturing

• Low-bioburden raw materials

• Protective packaging

• Controlled manufacturing hold times

The objective is not to accumulate as many antimicrobial ingredients as possible.

The objective is to create complementary conditions that make contamination less likely and microbial survival more difficult while maintaining product safety, sensory quality, regulatory compliance, and formula stability.

“Preservative-Free” Does Not Mean Unprotected

A product marketed as preservative-free may still rely on antimicrobial protection from:

• Multifunctional ingredients

• Organic acids

• Glycols

• Alcohol

• Low water activity

• Extreme pH

• Packaging controls

• A combination of preservation hurdles

The marketing claim does not change the microbiological expectation.

If the finished product can support microbial survival or growth under foreseeable conditions, its protection still needs scientific support.

The more useful question is not:

Does the ingredient list contain something consumers recognize as a preservative?

The useful question is:

Can the finished product remain microbiologically acceptable throughout manufacturing, storage, and intended use?

Clean Beauty Formulas Still Need Robust Preservation

Clean beauty standards may narrow the available preservative palette.

That can increase formulation complexity, particularly when the product also contains:

• Natural gums

• Botanical extracts

• Ferments

• Proteins

• Clays

• High electrolyte levels

• Fragrance restrictions

• Low-irritation requirements

• Retailer-specific prohibited lists

Clean formulation does not mean weak preservation.

It means the preservation system must be selected, designed, and tested with greater intention.

Replacing a conventional preservative with a fashionable alternative at the same percentage is not a preservation strategy.

A science-first clean beauty approach considers:

• Formula pH

• Raw-material quality

• Water activity

• Chelation

• Polymer compatibility

• Surfactant interactions

• Processing

• Packaging

• Consumer use

• PET performance

For a broader discussion of evidence-based clean formulation, see Clean Beauty 2.0: Why Clean Beauty Isn’t Dead, It’s Finally Growing Up.

Packaging Is Part of the Microbiological Risk Assessment

Packaging changes the frequency and manner in which contamination can enter a product.

Consider the differences among:

• Wide-mouth jar

• Airless pump

• Treatment pump

• Squeeze tube

• Dropper

• Roll-on

• Wand applicator

• Refillable package

• Wet-wipe pouch

• Shower product

An airless package may reduce direct consumer contact, but it does not eliminate contamination introduced through manufacturing or filling.

A jar may create greater in-use exposure, but a well-designed preservation system may still protect the product.

A refill format may support sustainability goals while creating new hygiene considerations.

The formula and the package should be evaluated as one commercial system.

When Should PET Be Performed?

Definitive PET should be performed when the formula is sufficiently finalized to represent the product being commercialized.

During early development

The formulator may conduct preliminary screening to compare preservation approaches.

These screens can identify weak systems and guide development, but they do not necessarily replace testing by a qualified microbiology laboratory.

After formula approval

The final or near-final formula should be submitted once critical variables are established, including:

• Preservative system

• pH

• Water content

• Surfactants

• Polymers

• Fragrance

• Actives

• Major botanical materials

• Manufacturing process

During scale-up

Retesting may be appropriate when pilot or production manufacturing introduces meaningful changes in:

• Equipment

• Shear

• Heating and cooling

• Batch size

• Addition order

• Hold times

• Filling process

• Raw-material handling

After aging

Depending on the risk and development plan, the product may be challenged after accelerated or real-time aging to determine whether antimicrobial protection remains adequate as the formula changes over time.

Preservatives can degrade, partition differently, or become less available as a product ages. FDA notes that preservatives can break down over time and that repeated consumer contact may introduce microorganisms.

Which Changes May Require Retesting?

Retesting should be considered when a modification could reasonably affect microbial protection.

Examples include:

• Changing the preservative

• Changing preservative concentration

• Changing pH

• Adding or removing water

• Changing water activity

• Changing the emulsifier

• Changing the surfactant system

• Changing a polymer or thickener

• Adding a botanical extract

• Adding protein, starch, clay, or fermentation-derived material

• Changing a chelator

• Adding fragrance or essential oil

• Changing glycol or solvent levels

• Changing a critical raw-material supplier

• Changing manufacturing equipment

• Changing processing temperature

• Changing addition order

• Changing package type

• Moving from a jar to a pump

• Introducing a refill

• Changing manufacturers

• Scaling from laboratory to commercial production

Not every small adjustment automatically requires a complete new PET.

The decision should be documented and based on scientific risk.

The question is not whether the ingredient-list change looks minor.

The question is whether the change could alter:

• Preservative availability

• pH

• water activity

• organism exposure

• raw-material bioburden

• processing

• package protection

What Should You Give the Testing Laboratory?

A microbiology laboratory can make better decisions when it understands the product.

Provide:

• Product type

• Cosmetic or drug classification

• Intended markets

• Leave-on or rinse-off status

• Application area

• Intended users

• Final pH

• Water activity, when known

• Preservative system

• Alcohol or solvent content

• Known antimicrobial ingredients

• Packaging type

• Intended use environment

• Full formula or sufficient composition information

• Ingredients that may interfere with recovery

• Whether the product is emulsified, water-soluble, anhydrous, pigmented, powdered, or difficult to disperse

• Relevant manufacturing concerns

• Any organism-specific risks

A laboratory should also know whether the formula contains ingredients capable of interfering with organism recovery or neutralization.

The test is stronger when it is adapted to the product rather than treated as a generic administrative exercise.

How to Read a PET Report

Do not stop at the word “pass.”

Review:

The protocol

Confirm that the method matches the product and regulatory purpose.

The organisms

Verify which organisms were included and whether additional product-relevant organisms were considered.

The time points

Understand when counts were measured.

The log reductions

Review how each organism responded throughout the study.

The acceptance category

Some methods distinguish different levels of acceptance. The report should explain what the result means.

The controls

Confirm that inoculum verification, recovery, and neutralization controls were acceptable.

The failure pattern

If the product failed, determine:

• Which organism failed

• When the failure occurred

• Whether the population declined initially

• Whether regrowth occurred

• Whether the weakness involved bacteria, yeast, mold, or several groups

The pattern can help guide reformulation.

What Should You Do When a Formula Fails PET?

A failed PET is disappointing, but it is useful information.

The failure occurred while the product could still be improved, not after consumers discovered the problem.

Confirm that the method was valid

Review:

• Test protocol

• Neutralization

• Recovery controls

• Inoculum verification

• Sample condition

• Shipping

• Storage

• Laboratory deviations

Identify the organism and timing

A failure against one mold may require a different strategy than broad bacterial and fungal failure.

Counts that decline and later rebound may suggest a different weakness than counts that never decline adequately.

Review the entire preservation system

Evaluate:

• pH

• Water activity

• Preservative concentration

• Preservative solubility

• Partitioning

• Polymer interactions

• Surfactant interactions

• Chelation

• Raw-material burden

• Processing

• Packaging

• Manufacturing hygiene

Make a targeted correction

Potential corrective actions may include:

• Adjusting pH

• Changing the preservative blend

• Adding a compatible co-preservative

• Adding or optimizing a chelator

• Reducing water activity

• Changing a polymer

• Modifying the surfactant system

• Changing processing temperature

• Improving dispersion

• Tightening raw-material specifications

• Improving package protection

• Improving manufacturing controls

Repeat the test

A reformulated product requires new evidence.

The original failure cannot be resolved through explanation alone.

Why “Just Add More Preservative” Is Often the Wrong Response

Increasing preservative concentration may sometimes improve performance, but it should not be the automatic first action.

More preservative may:

• Exceed regulatory limits

• Increase irritation potential

• Change odor

• Affect color

• Destabilize the formula

• Reduce consumer acceptance

• Conflict with retailer standards

• Fail to address binding or partitioning

• Leave fungal or bacterial gaps

• Create solubility problems

If the preservative is unavailable because it is bound to a polymer, adding more may not correct the underlying interaction.

If the pH is unsuitable, increasing concentration may be less effective than adjusting pH.

If the product is being contaminated during production, a stronger preservative is not a substitute for correcting manufacturing hygiene.

A failure should be diagnosed, not merely overpowered.

Common PET Mistakes

Testing too early

If the formula is still changing, the result may not represent the commercial product.

Testing too late

Waiting until thousands of units have been manufactured turns a development problem into an inventory problem.

Assuming supplier data is enough

Supplier studies help select ingredients. They do not prove performance in your finished formula.

Confusing microbial limits with PET

A clean sample today does not prove protection tomorrow.

Ignoring packaging

The use system influences contamination exposure.

Ignoring process changes

Scale-up can change preservative distribution, pH, dispersion, and finished-product structure.

Treating all laboratories as interchangeable

Method suitability, neutralization, recovery, experience, and report quality matter.

Focusing only on the preservative percentage

The whole formula determines performance.

Assuming “natural” means low risk

FDA explicitly notes that natural or organic sourcing is not a guarantee of safety.

Why PET Matters Commercially

Microbial protection is first a consumer-safety issue.

It is also a commercial issue.

A preservation failure can lead to:

• Reformulation

• Repeated testing

• Launch delays

• Destroyed inventory

• Product withdrawal

• Consumer complaints

• Returns

• Retailer concern

• Regulatory scrutiny

• Reputation damage

• Loss of customer trust

The cost of PET is small compared with the potential cost of discovering inadequate preservation after production.

It can also matter during:

• Retailer onboarding

• International expansion

• Product safety assessment

• Manufacturing transfer

• Acquisition due diligence

• Insurance review

• Regulatory inspection

• Formula modernization

Testing creates evidence.

Evidence makes technical decisions more defensible.

PET and Contract Manufacturing

Brands often assume that the contract manufacturer will manage all microbial testing automatically.

That should never be assumed.

Before manufacturing, clarify:

• Who selects the test method?

• Who pays for testing?

• Is PET performed on the development batch, pilot batch, or production batch?

• Will the manufacturer accept outside laboratory data?

• Does the manufacturer require its own confirmation?

• Who owns the report?

• What happens if the formula fails?

• Will production be delayed?

• Are microbial limits included in routine release testing?

• Are retained samples monitored?

• Who authorizes reformulation?

These responsibilities should be agreed upon before the commercial batch is scheduled.

For a broader explanation of how formulation partners and manufacturers divide responsibilities, read Custom Cosmetic Formulation vs. Contract Manufacturing: What’s the Difference?

PET and Technology Transfer

A formula that passed PET in the development laboratory may need reassessment after transfer if manufacturing changes affect the finished product.

Technology transfer can introduce differences in:

• Vessel geometry

• Mixer type

• Shear

• Temperature

• Cooling rate

• Water quality

• Batch hold time

• Raw-material suppliers

• Filling conditions

• Cleaning procedures

This is one reason Cosmeta formulates with scale and manufacturing in mind from the beginning. Its development model includes stability planning, process optimization, scale-up support, manufacturing documentation, and technology-transfer assistance.

The objective is not merely to create a formula that passes once.

It is to create a process capable of reproducing the same protected product consistently.

Suggested Image Placement

Place after “How Is a Preservative Efficacy Test Performed?”

A vertical black-and-white process graphic:

FORMULA SUBMISSION
↓
METHOD SUITABILITY
↓
MICROBIAL CHALLENGE
↓
SAMPLING & RECOVERY
↓
LOG-REDUCTION ANALYSIS
↓
PASS, INVESTIGATE, OR REFORMULATE

ALT text:

Steps in cosmetic Preservative Efficacy Testing from formula submission through microbial analysis.

Key Takeaways

• PET evaluates the antimicrobial protection of the finished formula, not simply the presence of a preservative.

• The product is deliberately challenged with representative microorganisms and evaluated over time.

• PET is different from microbial limits testing, physical stability, and packaging compatibility.

• A low initial microbial count does not prove that a product is adequately preserved.

• ISO 11930 is a major cosmetic reference method, while pharmaceutical or OTC products may require different methods.

• Not every cosmetic requires PET, but a low-risk determination should be scientifically documented.

• Anhydrous and preservative-free products are not automatically exempt from microbial risk.

• pH, water activity, polymers, surfactants, raw materials, process, packaging, and manufacturing hygiene can all influence preservation.

• A failed PET should trigger investigation, not an automatic increase in preservative concentration.

• Significant changes to the formula, process, package, manufacturer, or raw-material supply may justify retesting.

• PET does not establish complete shelf life.

• Preservation should be designed into the product from the beginning rather than added after formulation is otherwise complete.

Cosmeta’s Perspective

Preservation is often discussed as though it were a choice between individual ingredients.

Phenoxyethanol or organic acids.

Traditional or natural.

Conventional or clean.

Those comparisons are incomplete.

The real preservation decision is the design of the entire product system.

Who will use it?

Where will it be stored?

Will wet fingers enter the package?

Does the formula contain botanicals, proteins, ferments, clays, gums, or other materials that increase complexity?

Will the package protect the product or repeatedly expose it?

What processing conditions will the preservative experience?

Which markets and retailer standards must the product meet?

The answers influence formulation architecture long before a final preservative percentage is selected.

At Cosmeta, we view microbial protection as a connection between formulation, raw-material quality, pH, water activity, packaging, processing, manufacturing hygiene, consumer behavior, and regulatory strategy.

The goal is not to use the strongest possible preservative at the highest possible concentration.

The goal is to build the most thoughtful system capable of protecting the product while supporting skin compatibility, sensory quality, stability, regulatory compliance, and the brand’s ingredient philosophy.

That requires scientific judgment.

It also requires humility.

A preservative system that worked in ten previous formulas may behave differently in the eleventh because the new product contains a different polymer, surfactant, active, botanical, package, or manufacturing process.

Testing is where assumption ends, and evidence begins.

That is why PET should not be treated as a regulatory box to check.

It is one of the ways a brand demonstrates that the product was developed responsibly, that microbial risk was taken seriously, and that consumer trust is supported by more than an ingredient story.

Ready for the Next Step

Define the microbial strategy before the formula, package, and manufacturing process are locked.

Early planning gives the development team more options, reduces expensive late-stage changes, and creates a clearer path from formulation through testing and commercial production

FAQS

• How long does Preservative Efficacy Testing take?

  Many standard cosmetic challenge tests run for approximately 28 days. The exact schedule depends on the selected protocol, product classification, organisms, sampling intervals, and laboratory procedures.

• How much product does a laboratory need for PET?

  Sample requirements vary by laboratory, method, product type, and the number of organisms tested. Ask the laboratory for its required quantity before preparing samples. Send enough material from one representative batch whenever possible.

• Can a product pass PET without a conventional preservative?

  Yes. A formula may rely on multifunctional ingredients, low water activity, pH, alcohol, glycols, packaging, or several complementary hurdles. The finished product still needs appropriate evidence of antimicrobial protection when its risk profile warrants testing.

• Is PET the same as microbial limits testing?

  No. Microbial limits testing evaluates the microorganisms present in a product sample at the time of testing. PET evaluates whether the product can control microorganisms deliberately introduced during the study.

• Can a product pass microbial limits and fail PET?

  Yes. A product may be manufactured with a very low initial microbial count but still lack enough antimicrobial protection to control contamination introduced during later use.

• Can a product pass PET and fail microbial limits?

  Yes. A capable preservation system does not excuse contamination caused by poor water quality, raw materials, sanitation, filling, storage, or manufacturing controls.

• Do anhydrous cosmetics require PET?

  Some genuinely anhydrous products may qualify as microbiologically low risk. However, the decision should consider water introduction during use, package design, raw materials, water activity, manufacturing conditions, and foreseeable consumer behavior.

• Does an airless pump eliminate the need for PET?

  No. Airless packaging may reduce consumer exposure but does not eliminate contamination introduced through raw materials, manufacturing, filling, or package components. Packaging should be considered as one part of the risk assessment.

• Should PET be performed before or after stability testing?

  The studies may overlap. Definitive PET should be performed on a formula that is sufficiently finalized to represent the commercial product. Depending on risk, a product may also be challenged after accelerated or real-time aging to confirm that preservation remains effective.

• Does PET prove the product’s shelf life?

  No. PET supports antimicrobial protection. Shelf-life substantiation may also require physical stability, chemical stability, packaging compatibility, microbial limits, active-content testing, and other product-specific evaluations.

• What is the difference between ISO 11930 and USP <51>?

  ISO 11930 is designed for evaluation of the antimicrobial protection of cosmetic products. USP <51> is a pharmacopeial antimicrobial effectiveness method used for applicable pharmaceutical products. Product classification and market determine which method is appropriate.

• Is PET required for cosmetics sold in the United States?

  FDA does not prescribe one universal PET method for every cosmetic. However, cosmetic companies are responsible for product safety and adequate safety substantiation. For water-containing products with foreseeable contamination risk, PET may be important evidence supporting microbial safety.

• Is challenge testing required for cosmetics sold in the European Union?

  EU safety documentation must address microbiological quality and include challenge-test information when applicable. SCCS guidance states that challenge testing is expected for products that may deteriorate or create infection risk under normal storage and use.

• Should every production batch undergo PET?

  Not usually. PET is generally used to qualify the preservation system of the commercial formula. Routine batch release commonly relies on microbial limits and other quality specifications. Requalification may be appropriate after significant formula, process, supplier, packaging, or manufacturing changes.

• Can fragrance affect PET performance?

  Yes. Fragrance materials may affect preservative solubility, partitioning, pH, emulsion structure, or antimicrobial activity. A fragrance-free base that passes PET does not automatically prove that every fragranced version will perform identically.

• Can changing the thickener cause a PET failure?

  Yes. Polymers can alter water structure, preservative availability, pH, viscosity, neutralization, and organism recovery. Even a seemingly small thickener change may affect microbial protection.

• What happens if mold fails but bacteria pass?

  The failure pattern suggests that bacterial protection may be stronger than fungal protection, but the complete formulation and test method still need investigation. Review preservative spectrum, pH, water activity, packaging, raw materials, processing, and laboratory recovery before deciding how to reformulate.

• Can a failed PET result be overridden by a risk assessment?

  A documented risk assessment can help interpret a product’s microbiological risk, but it should not be used casually to dismiss a valid failure in a product that requires antimicrobial protection. A failed result normally warrants investigation, corrective action, and new supporting evidence.

• Should the final production batch be tested if a laboratory prototype passed?

  It may be appropriate when scale-up changes equipment, processing, raw-material handling, water quality, batch hold times, filling, or other critical variables. The decision should be based on documented risk and the expectations of the manufacturer, regulator, safety assessor, or retailer.

• Who should perform PET?

  A qualified microbiology laboratory with experience in cosmetic or pharmaceutical products, appropriate methods, validated recovery and neutralization procedures, and reporting sufficient to support technical interpretation.

No results found